Extreme Elevations of Alkaline Phosphatase in Pregnancy: A Case Report by Stanley, Zachary et al.
University of Kentucky 
UKnowledge 
Obstetrics and Gynecology Faculty Publications Obstetrics and Gynecology 
7-2020 
Extreme Elevations of Alkaline Phosphatase in Pregnancy: A Case 
Report 
Zachary Stanley 
University of Kentucky, z.stanley@uky.edu 
Katherine Vignes 
University of Kentucky, katherine.vignes@uky.edu 
Miriam Marcum 
University of Kentucky, miriam.marcum@uky.edu 
Follow this and additional works at: https://uknowledge.uky.edu/obgyn_facpub 
 Part of the Obstetrics and Gynecology Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Repository Citation 
Stanley, Zachary; Vignes, Katherine; and Marcum, Miriam, "Extreme Elevations of Alkaline Phosphatase in 
Pregnancy: A Case Report" (2020). Obstetrics and Gynecology Faculty Publications. 27. 
https://uknowledge.uky.edu/obgyn_facpub/27 
This Article is brought to you for free and open access by the Obstetrics and Gynecology at UKnowledge. It has 
been accepted for inclusion in Obstetrics and Gynecology Faculty Publications by an authorized administrator of 
UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
Extreme Elevations of Alkaline Phosphatase in Pregnancy: A Case Report 
Digital Object Identifier (DOI) 
https://doi.org/10.1016/j.crwh.2020.e00214 
Notes/Citation Information 
Published in Case Reports in Women's Health, v. 27, e00214. 
© 2020 The Authors 
This is an open access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-
nc-nd/4.0/). 
This article is available at UKnowledge: https://uknowledge.uky.edu/obgyn_facpub/27 
Extreme elevations of alkaline phosphatase in pregnancy: A case report
Zachary Stanley ⁎, Katherine Vignes, Miriam Marcum
Obstetrics & Gynecology, University of Kentucky, 800 Rose St, C-368, Lexington, KY 40536, United States of America
a b s t r a c ta r t i c l e i n f o
Article history:
Received 15 April 2020
Received in revised form 28 April 2020
Background: The normal serum concentration of alkaline phosphatase (ALP) in adults over the age of 18 ranges
from 37 to 116 U/L, while in pregnant women levels of up to twice that upper limit can still be normal. There
have been very few reports of extreme elevations in ALP, and herewe present the case of a 29-year-old pregnant
woman with an incidentally found 30-fold increase.
Case: The patient, G6P2–1–2-4, received routine prenatal care, though presented to obstetric triage at 36 weeks
and 1 day of gestation for diagnosis andmanagement of viral rhinosinusitis andwas found to have anALP level of
2817 U/L. She was expectantly managed and levels were monitored during the peripartum period.
Conclusion: The literature proposes that elevation of the placental isotype of ALP could be a marker for placental
insufficiency, preterm delivery, or infants born large for gestational age. We report a case with delivery of a nor-
mal infant and no placental pathology at term.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Although obstetricians have observed elevations in serum alkaline
phosphatase (ALP) during pregnancy, these typically are not much
more than twice the pre-pregnancy upper limit of normal [1]. There is
currently a paucity of cases in which exaggerated increases are ob-
served. Seeing an atypically elevated value can be distressing to both
the clinician and the patient, especially when it is unknown what the
implicationsmay be. Some retrospective and prospective cohort studies
have shown that ALP could be a marker for preterm delivery, fetuses
that are large for gestational age, or conversely placental insufficiency
and intrauterine growth restriction [2,3,4]. This case serves to add to
the literature as a demonstration that even abnormal elevations of ALP
do not reliably predict fetomaternal pathology. This case is important
because it highlights the association between a very abnormal
biochemical value and good fetomaternal outcomes after expectant
management.
2. Case
A 29-year-oldwoman, gravida 6 para 2–1–2-4, received routine pre-
natal care at an academic practice at a universitymedical center. Her ob-
stetric history was significant for a preterm cesarean section of a
monochorionic, diamniotic twin pregnancy at 33weeks aswell as a suc-
cessful vaginal birth after cesarean. Her routine laboratory tests were
unremarkable, including a normal glucose tolerance test at 26 weeks.
An anatomy ultrasound at 21 weeks of gestation was within normal
limits. Her placental location was posterior with no correlation to her
previous cesarean scar. She presented to the obstetric triage unit at
36 weeks and 1 day of gestation with complaints of shortness of breath
and nasal congestion. Her workup was significant for positive human
rhinovirus/enterovirus nasopharyngeal cultures. A comprehensivemet-
abolic panel (CMP), which tests for serumelectrolytes aswell as hepatic
and renal function, was obtained as a part of her initial workup and in-
cidentally showed an elevated ALP level of 2817U/L. Shewas sent home
with recommendations for supportive care and was scheduled to
follow-up for routine prenatal care the following day in clinic. At her of-
fice visit, a repeat CMP showed a continued ALP elevation, at 3143 U/L.
Fundal heights were consistently appropriate for gestational age. At her
next prenatal check the followingweek, the patientwas still having per-
sistent upper respiratory symptoms, for which a short course of
azithromycin was prescribed and another CMPwith ALP isoenzyme dif-
ferentiation was obtained. This showed a markedly elevated placental
isoenzyme, with low levels of both the liver and bone isoenzymes.
Knowing this breakdown, along with the absence of right upper quad-
rant pain, jaundice, or other signs of hepatic dysfunction, allowed an in-
vestigation for any liver pathology to be safely forgone. In the absence of
other indications for delivery, the shared decision was to plan for
another trial of labor after cesarean section at 39 weeks. Her labor was
induced with a Foley balloon and Pitocin. She had a successful vaginal
delivery of a viable, male, 3160-g infant. She received routine postpar-
tum care. ALP levels were checked immediately postpartum
(2767 U/L), at two weeks postpartum (702 U/L), and at her six-week
postpartumvisit (191 U/L). Thus the placental isoenzyme of ALPwas el-
evated up until the second week after delivery. Laboratory tests six
weeks postpartum were unable to detect any placental isoenzyme.
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3. Discussion
Serum ALP has several different sources, but is found in all tissues of
the body. Each isotypehas a uniquemolecularfingerprint based on its or-
igin. Themain isotypes are found in the liver, bone, and placenta and they
are key enzymes inmanymetabolic pathways. If we had not known that
the increase was due to the placental isotype, there are other diagnoses
thatwould rise to the topof the list.Weclassically seemoderate increases
in ALP associated with liver disease, which has a myriad of potential eti-
ologies. When ALP is disproportionately elevated in comparison to he-
patic transaminases and bilirubin, it is typically caused by an
obstructive disease process such as with cholelithiasis. As alluded to
above, previous case reports and small prospective and retrospective
studieshave attempted tounderstand the significanceof abnormal eleva-
tions in serum ALP during pregnancy. In 1995, a retrospective review of
blood samples of womenwho underwent preterm delivery had elevated
ALP placental isoenzyme levels when compared to blood samples of
women who delivered at term [2]. In 2018, a prospective cohort study
found a correlation between early elevations of ALP (at 13–16 weeks of
gestation) and babies born large for gestational age, even in the setting
of normal glucose tolerance testing [3]. A case report from 2019 presents
a patient with elevated ALP levels and signs of placental insufficiency
with elevated umbilical artery dopplers and intrauterine growth restric-
tion [4]. Our patient did not have any placental abnormalities, such as la-
cunae, and as its location was posterior, concern was low for abnormal
placentation. This is a case of an extremely elevated placental isoenzyme
of ALP in which the patient had low-risk outcomes for both the mother
and thebaby. This serves as a reminder thatwecannot reliablyuse an iso-
lated,marked increase in serumALP todictatemanagement in the setting
of an otherwise normal pregnancy.
Teaching Point
• Extreme elevations in alkaline phosphatase during pregnancymay be ex-
pectantly managed in the absence of other fetomaternal considerations.
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